Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marel Investor Presentation 2015

Oct 29, 2015

2191_rns_2015-10-29_9d74bbb8-8375-4625-858f-8fab40824e3e.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

img-0.jpeg

Q3 2015 Presentation

October 29, 2015

iMareI

Innovation Through Partnership®


iMareI Innovation Through Partnership

img-1.jpeg

Arni Oddur Thordarson, CEO


imarel Innovation Through Partnership

Strong order intake and robust operational performance

  • Revenue of €189 million [Q3 2014: 188m]
  • Good geographical and product mix
  • Order intake of €211 million [Q3 2014: 200m]
  • Adj. EBIT €24.2 million or 12.8% [Q3 2014: 9.3%]
  • Adj. EBITDA €31.6 million or 16.7% [Q3 2014: 13.8%]
  • Net result €14.7 million [Q3 2014: 9.8m]
  • Earnings per share 2.07 eurocents [Q3 2014: 1.34]

img-2.jpeg
* Refocusing costs in Q3 2015 amount to €2.0 million


imarel
Innovation Through Partnership

Order book at a good level

img-3.jpeg


imarel
Innovation Through Partnership

Solid operational performance with strong cash flow

img-4.jpeg

  • Adj. EBIT €24.2 million or 12.8% [Q3 2014: 9.3%]
  • Marel has streamlined its operations and focused its product portfolio
  • Discontinued low margin business accounts for 30 million annually and is not included in the accounts since Q2 2015
  • Marel has optimized its manufacturing footprint leading to improved margins
  • Year to date revenue is €617 million and adj. EBIT is €78 million (12.6%) compared with €513 million and €33 million (6.4%) respectively during same period last year
  • Order book has good product and geographical mix and now stands at €188 million compared with €169 million in Q3 2014

EBITDA improvement and strong cash flow has driven Net Debt/adj. EBITDA down to 1.1


imarel Innovation Through Partnership

Business overview for the first nine months of 2015

Other segments such as vegetable and cheese account for 1% of revenue

img-5.jpeg

Poultry

Very strong first nine months of the year with good volume and profitability

Good mix of greenfields, modernization, and maintenance business around the globe

55% of revenue
17.8% adj. EBIT

img-6.jpeg

Fish

Good first nine months of the year for Marel's fish segment

Conditions in salmon and white fish segments remain favorable

FleXicut continues to impress customers and good sales were seen in salmon filleting machines in the third quarter

17% of revenue
9.3% adj. EBIT

img-7.jpeg

Meat

Good improvement in profitability compared to previous years

Good activity in third quarter with landmark orders from Mexico and China

Product mix will lead to lower profitability in Q4 than YTD

15% of revenue
9.2% adj. EBIT

img-8.jpeg

Further Processing

Streamlining of activities continued with the ongoing transfer of activities from Des Moines to Gainesville

Further streamlining and investments planned to strengthen Marel's position in the convenience food market

12% of revenue
-2.6% adj. EBIT


imarel
Innovation Through Partnership

img-9.jpeg

Linda Jonsdottir, CFO


Business results

marel Innovation Through Partnership

EUR thousands Q3 2015 Q3 2014 Change in %
Revenue 189,106 187,931 0.6
Gross profit before refocusing cost 73,923 67,372 9.7
as a % of revenue 39.1 35.8
Before refocusing costs
Result from operations (adjusted EBIT) 24,166 17,409 38.8
as a % of revenue 12.8 9.3
Adjusted EBITDA 31,636 25,912 22.1
as a % of revenue 16.7 13.8
After refocusing costs
Result from operations (EBIT) 22,206 16,113 37.8
as a % of revenue 11.7 8.6
EBITDA 29,686 24,616 20.6
as a % of revenue 15.7 13.1
Net result 14,698 9,841 49.3
Orders received (including service revenues) 210,940 200,747 5.1
Order book 187,722 169,242 10.9

imarel

Firm steps taken to improve profitability

img-10.jpeg


imarel
Innovation Through Partnership

Order book grew by EUR 22 million between quarters

img-11.jpeg

Order book at the end of Q3 reflects continued operations and refocused product portfolio


imarel
Innovation Through Partnership

Condensed consolidated balance sheet

ASSETS (EUR thousands)

30/9 2015 31/12 2014
Non-current assets
Property, plant and equipment 85,155 96,139
Goodwill 388,811 387,103
Other intangible assets 105,708 114,916
Receivables 441 94
Deferred income tax assets 9,965 7,873
590,080 606,125
Current assets
Inventories 96,210 88,450
Production contracts 30,390 29,123
Trade receivables 78,020 77,125
Assets held for sale 4,899 2,500
Other receivables and prepayments 25,928 23,551
Cash and cash equivalents 92,119 24,566
327,566 245,315
Total assets 917,646 851,440

iimarel Innovation Through Partnership

Condensed consolidated balance sheet (continued)

LIABILITIES AND EQUITY (EUR thousands) 30/9 2015 31/12 2014
Equity 434,339 427,498
LIABILITIES
Non-current liabilities
Borrowings 223,951 180,278
Deferred income tax liabilities 15,499 11,308
Provisions 11,282 7,292
Derivative financial instruments 4,346 5,399
255,078 204,277
Current liabilities
Production contracts 73,673 64,958
Trade and other payables 120,615 122,479
Current income tax liabilities 6,365 4,185
Borrowings 18,462 18,635
Provisions 9,114 9,408
228,229 219,665
Total liabilities 483,307 423,942
Total equity and liabilities 917,646 851,440

imarel
Innovation Through Partnership

Q3 2015 cash flow composition and change in net debt

Operating activities (before interest & tax) Tax Invest-ment activities Free cash flow Net finance cost Purchase of Treasury shares Other items* Decrease in net debt
1.5 million
29.7 million 4.9 million 23.3 million 2.9 million 13.8 million 0.9 million 5.7 million
  • Tax on dividend, currency effect and change in capitalized finance charges

Anatel Innovation Through Partnership

Ample room for stimulating further growth

  • Net debt /adj.EBITDA is 1.12 x EBITDA compared with target of 2-3 x EBITDA
  • Marel is stimulating further revenue and operational profit growth by:
  • Streamlining the business
  • Continuous innovation
  • Investing in the business
  • In Q3 Marel acquired 10 million treasury shares for the total amount of €13.8 million. In Q2 Marel acquired 15 million treasury shares for €18.2 million.
  • Marel holds 31.7 million treasury shares, whereof 6.7 million are hedged towards outstanding stock options and 25 million were acquired to use in relations with future acquisitions

img-12.jpeg


iMareI Innovation Through Partnership

img-13.jpeg

Arni Oddur Thordarson, CEO


Good mix of Greenfields, Modernization and Maintenance

marel Innovation Through Partnership

Modernization and standard equipment

  • Investment in expansion and modernization projects picking up, especially in the Americas and in Europe

img-14.jpeg

Greenfields

  • Small and medium-sized greenfield projects in all segments and large-scale projects in poultry, meat and further processing in Q3 2015

Maintenance

  • Marel has the largest installment base in its industry
  • Recurring service and spare parts revenues increasing steadily and are currently around 40% of total revenues

imarel
Innovation Through Partnership

Strategic acquisitions and strong organic growth

  • Marel shares were listed at the Icelandic Stock Exchange in 1992 with revenue of €6 million and 45 employees – focus on the fish industry
  • Marel is currently a global leader in providing advanced equipment for the poultry, meat and fish industry with 4,000 employees operating in 32 countries
  • Organic revenue growth has been 6% per year post Stork Food System acquisition in 2008 and earnings per share have grown 20% per year

img-15.jpeg


Simpler, Smarter, Faster: 2014-2015
Full potential

Product portfolio optimized

img-16.jpeg

At the customer, for the customer

Manufacturing footprint optimized

2014

Revenue growth 7.7%

Adj. EBIT €48.8 m

Free cash flow €75.5m

Cash-out cost to date €14 million compared to estimated total cash-out cost of below €25 million throughout the program

2015 year-to-date

Revenue €617m

Adj. EBIT €77.7m

Free cash flow €70.6m

2016

Organic growth

Solid operational improvement

Good cash conversion

2017

Organic growth

> €100 million EBIT

Good cash conversion


Cmarel Innovation Through Partnership

img-17.jpeg

Thank you
Takk fyrir
Dank u wel
Mange tak


Disclaimer

marel
Innovation Through Partnership

This Presentation is being furnished for the sole purpose of assisting the recipient in deciding whether to proceed with further analysis of this potential opportunity. This Presentation is for informational purposes only and shall not be construed as an offer or solicitation for the subscription or purchase or sale of any securities, or as an invitation, inducement or intermediation for the sale, subscription or purchase of securities.

The information set out in this Presentation may be subject to updating, completion, revision and amendment and such information may change materially. Even though Marel hf. has given due care and attention in the preparation of this Presentation, no representation or warranty, express or implied, is or will be made by Marel hf. as to the accuracy, completeness or fairness of the information or opinions contained in this Presentation and any reliance the recipient places on them will be at its own sole risk. Without prejudice to the foregoing, Marel hf. does not accept any liability whatsoever for any loss howsoever arising, directly or indirectly, from use of this Presentation or its contents or otherwise arising in connection therewith. Any recipient of this Presentation is recommended to seek its own financial advice.

There is no representation, warranty or other assurance that any of the projections in the Presentation will be realized. The recipient should conduct its own investigation and analysis of the business, data and property described herein. Any statement contained in this Presentation that refers to estimated or anticipated future results or future activities are forward-looking statements which reflect current analysis of existing trends, information and plans. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially and could adversely affect the outcome and financial effects of the plans and events described herein. As a result, the recipient is cautioned not to place undue reliance on such forward-looking statements.

Transactions with financial instruments by their very nature involve high risk. Historical price changes are not necessarily an indication of future price trends. Any recipient of this Presentation are encouraged to acquire general information from expert advisors concerning securities trading, investment issues, taxation, etc. in connection with securities transactions.

This Presentation and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of Marel hf. By accepting this Presentation the recipient has agreed, upon request, to return promptly all material received from Marel hf. (including this Presentation) without retaining any copies. In furnishing this Presentation, Marel hf. undertakes no obligation to provide the recipient with access to any additional information or to update this Presentation or to correct any inaccuracies therein which may become apparent.

The distribution of this Presentation, or any of the information contained in it, in other jurisdictions than the Republic of Iceland may be restricted by law, and persons into whose possession this Presentation comes should inform themselves about, and observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the laws of any such other jurisdictions.